Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00581958 · ClinicalTrials.gov registry record
Radiation Biodosimetry in Patients Treated With Total Body Irradiation (TBI)
A clinical trial of Cancer, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 198
- Enrollment target
- 1
- Study location
NCT00581958: Completed study of Cancer, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00581958 is a study of Cancer that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 198 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00581958, a study of Cancer, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 198 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to develop blood tests and urine tests that can tell doctors how much radiation a person has been exposed to. Doctors know how much radiation patients are exposed to in certain medical situations. An example of this would be radiation treatment for cancer. Radiation treatment machines are programmed to give exact doses of radiation.
Conditions Studied
Interventions
- OTHER Blood Samples
Study Locations (1)
New York
- Memorial Sloan Kettering Cancer Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 198 participants |
| Start Date | 2007-11 |
| Est. Completion | 2018-10-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00581958
The ClinicalTrials.gov registry entry for NCT00581958 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 198 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (94% lower). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which Blood Samples is the first listed.
NCT00581958 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT00581958 about?
NCT00581958 is a clinical study titled "Radiation Biodosimetry in Patients Treated With Total Body Irradiation (TBI)". The purpose of this study is to develop blood tests and urine tests that can tell doctors how much radiation a person has been exposed to. Doctors know how much radiation patients are exposed to in certain medical situations. An example of this would be radiation treatment for cancer. Radiation trea...
What is the current status of trial NCT00581958?
This trial is currently completed. The enrollment target is 198 participants. The study started on 2007-11. Estimated completion is 2018-10-31.
What conditions does trial NCT00581958 study?
This clinical trial studies the following conditions: Cancer.
What interventions are being tested in trial NCT00581958?
The interventions under investigation include: Blood Samples (OTHER).
Who is sponsoring clinical trial NCT00581958?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00581958 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated with Radiation
RECRUITING
-
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
RECRUITING · Phase 2
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
RECRUITING · Phase 1
-
Long-Term Follow-Up of Recipient of Gene Transfer Research
RECRUITING
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.